免疫沉淀-质谱法揭示类风湿关节炎中已知和新型抗核抗体(NatC、BCS1L)
该研究用免疫沉淀-质谱法(IP-MS)分析51例ANA阳性、未用DMARD的RA患者血清,在10例中检出自身抗原,包括SSA-Ro60、SSB-La等已知靶点及NatC复合物和BCS1两个新自身抗原;后两者在健康人和其他系统性风湿病中未检出,提示可能作为新型生物标志物。
要点
- IP-MS在10/51例ANA阳性RA患者中检出自身抗原,滴度≥1/640者检出率较高。
- 发现NatC复合物和BCS1为新自身抗原,在健康人和其他风湿病中未检出。
- RA相关自身抗原谱多样,包括SSA-Ro60、SSB-La、Ku、fibrillarin等。
核心结论
- IP-MS揭示ANA阳性RA患者存在多样自身抗原谱,包括未报道的NatC和BCS1,提示其作为潜在新型生物标志物。
研究设计与样本
- 研究纳入51例ANA阳性、未用DMARD的RA患者血清,用HeLa核或胞质提取物进行IP-MS,并在43名健康人和88例其他系统性风湿病患者中评估新抗原 prevalence。
主要发现
- 51例RA中10例检出自身抗原:滴度1/160者2/29,1/320者4/12,≥1/640者4/10。
- 检出的已知抗原包括SSA-Ro60、SSB-La、Ku、fibrillarin、线粒体多酶复合物组分、Argonaute 1/2/3、TIA-1和TIAR。
- 新发现的NatC复合物和BCS1在健康人及其他系统性风湿病患者中均未检出。
临床怎么用
- 对于ANA阳性但常规自身抗体阴性的RA患者,IP-MS可辅助识别已知和新型自身抗原。
- NatC和BCS1抗体可能作为RA新型生物标志物,但临床相关性需进一步研究。
局限性
- 样本量较小(51例RA),新抗原的临床意义尚未评估,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In a fraction of patients with rheumatoid arthritis (RA), antinuclear antibodies (ANA) are present. However, in most ANA-positive samples from patients with RA, no autoantigens can be identified. We aimed to characterise the ANA landscape in RA and to identify known and novel autoantigens using an unbiased immunoprecipitation-mass spectrometry (IP-MS) approach. METHODS: Sera from 51 ANA-positive, DMARD-naïve patients with RA were analysed by IP-MS using HeLa nuclear or cytoplasmic extracts (depending on the ANA staining pattern). Immunoprecipitated proteins were digested and identified using liquid chromatography coupled with MS. The prevalence of new or unfamiliar autoantigens was assessed in 43 healthy individuals and 88 ANA-positive individuals with a systemic rheumatic disease (systemic lupus erythematosus, Sjögren's disease, systemic sclerosis and idiopathic inflammatory myopathy). RESULTS: Autoantigens were detected in 10 of 51 RA samples (in 2/29 with titre 1/160, in 4/12 with titre 1/320 and in 4/10 with titre ≥1/640). Autoantigens identified included SSA-Ro60, SSB-La, Ku, fibrillarin, components of the mitochondrial multienzyme complex, protein argonaute 1, 2, 3 and T-cell restricted intracellular antigen 1 and TIA-1-related protein. Two novel autoantigens were discovered: the N-terminal acetyltransferase C (NatC) complex and mitochondrial chaperone BCS1. Neither NatC nor BCS1 was detected in healthy individuals or individuals with other systemic rheumatic diseases. CONCLUSION: IP-MS revealed a diverse spectrum of autoantigens in patients with ANA-positive RA, including previously unreported targets. These findings expand our knowledge of RA-associated autoimmunity and highlight antibodies to NatC and BCS1 as potential novel biomarkers. Further studies are needed to assess their clinical relevance.
引用
- De Leeuw J, Michiels B, Derua R, et al. Immunoprecipitation-mass spectrometry reveals known and novel (NatC, BCS1L) antinuclear antibodies in rheumatoid arthritis. RMD Open. 2026. PMID: 41963076. doi:10.1136/rmdopen-2025-006642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。